OBJECTIVES: This study was designed to evaluate the characteristics of gadolinium-enhanced imaging of radiofrequency ablations. BACKGROUND: Gadolinium-enhanced magnetic resonance imaging (MRI) has been used successfully to evaluate tissue necrosis after myocardial infarction. In electrophysiology, radiofrequency energy is used to create a targeted myocardial necrosis for the treatment of various arrhythmias. METHODS: Using a power-controlled, cooled-tip 7-F catheter system, radiofrequency lesions (10 to 40 W for 30 s) were created on the epicardium of the right ventricle in eight mongrel dogs. After injection of 0.225 mmol/kg gadolinium, T1-weighted fast gradient echo images were obtained during a follow-up of 10 h using an intrathoracic high-resolution coil. Radiofrequency ablations were analyzed on the MR images and compared with gross anatomy and histopathology. RESULTS: Four distinct phases of signal enhancement were observed. After gadolinium injection, radiofrequency lesions were delineated clearly as contrast-free areas of low signal intensity (contrast-to-noise ratio [CNR] = -21.1 +/- 19.8). Signal enhancement in the lesion periphery started 4.0 +/- 1.8 min after injection and progressively extended toward the lesion center at a rate of 0.02 mm/min. Full delayed enhancement was observed after 98 +/- 21 min (CNR = +17.8 +/- 9.0). During the follow-up period, CNR started to decrease, but the lesions were detectable for as long as 10 h of follow-up. During the first three phases of enhancement, MRI correlated well with the pathological findings (r = 0.88, r = 0.88, and r = 0.86 [p < 0.001], respectively). CONCLUSIONS: Radiofrequency ablation can be evaluated accurately by using gadolinium-enhanced MRI, which may allow the noninvasive assessment of procedural success. The dissimilar wash-in and wash-out kinetics compared with myocardial infarction suggest a different pathophysiological process with complete loss of microvasculature.
OBJECTIVES: This study was designed to evaluate the characteristics of gadolinium-enhanced imaging of radiofrequency ablations. BACKGROUND:Gadolinium-enhanced magnetic resonance imaging (MRI) has been used successfully to evaluate tissue necrosis after myocardial infarction. In electrophysiology, radiofrequency energy is used to create a targeted myocardial necrosis for the treatment of various arrhythmias. METHODS: Using a power-controlled, cooled-tip 7-F catheter system, radiofrequency lesions (10 to 40 W for 30 s) were created on the epicardium of the right ventricle in eight mongrel dogs. After injection of 0.225 mmol/kg gadolinium, T1-weighted fast gradient echo images were obtained during a follow-up of 10 h using an intrathoracic high-resolution coil. Radiofrequency ablations were analyzed on the MR images and compared with gross anatomy and histopathology. RESULTS: Four distinct phases of signal enhancement were observed. After gadolinium injection, radiofrequency lesions were delineated clearly as contrast-free areas of low signal intensity (contrast-to-noise ratio [CNR] = -21.1 +/- 19.8). Signal enhancement in the lesion periphery started 4.0 +/- 1.8 min after injection and progressively extended toward the lesion center at a rate of 0.02 mm/min. Full delayed enhancement was observed after 98 +/- 21 min (CNR = +17.8 +/- 9.0). During the follow-up period, CNR started to decrease, but the lesions were detectable for as long as 10 h of follow-up. During the first three phases of enhancement, MRI correlated well with the pathological findings (r = 0.88, r = 0.88, and r = 0.86 [p < 0.001], respectively). CONCLUSIONS: Radiofrequency ablation can be evaluated accurately by using gadolinium-enhanced MRI, which may allow the noninvasive assessment of procedural success. The dissimilar wash-in and wash-out kinetics compared with myocardial infarction suggest a different pathophysiological process with complete loss of microvasculature.
Authors: A C Lardo; E R McVeigh; P Jumrussirikul; R D Berger; H Calkins; J Lima; H R Halperin Journal: Circulation Date: 2000-08-08 Impact factor: 29.690
Authors: E M Merkle; D T Boll; T Boaz; J L Duerk; Y C Chung; G H Jacobs; M E Varnes; J S Lewin Journal: Magn Reson Med Date: 1999-07 Impact factor: 4.668
Authors: R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd Journal: Circulation Date: 1999-11-09 Impact factor: 29.690
Authors: C Pappone; S Rosanio; G Oreto; M Tocchi; F Gugliotta; G Vicedomini; A Salvati; C Dicandia; P Mazzone; V Santinelli; S Gulletta; S Chierchia Journal: Circulation Date: 2000-11-21 Impact factor: 29.690
Authors: W J Rogers; C M Kramer; G Geskin; Y L Hu; T M Theobald; D A Vido; S Petruolo; N Reichek Journal: Circulation Date: 1999-02-16 Impact factor: 29.690
Authors: R M Judd; C H Lugo-Olivieri; M Arai; T Kondo; P Croisille; J A Lima; V Mohan; L C Becker; E A Zerhouni Journal: Circulation Date: 1995-10-01 Impact factor: 29.690
Authors: Timm Dickfeld; Ritsushi Kato; Menekem Zviman; Saman Nazarian; Jun Dong; Hiroshi Ashikaga; Albert C Lardo; Ronald D Berger; Hugh Calkins; Henry Halperin Journal: Heart Rhythm Date: 2006-11-01 Impact factor: 6.343
Authors: Ravi Ranjan; Ritsushi Kato; Menekhem M Zviman; Timm M Dickfeld; Ariel Roguin; Ronald D Berger; Gordon F Tomaselli; Henry R Halperin Journal: Circ Arrhythm Electrophysiol Date: 2011-04-14
Authors: Ehud J Schmidt; Maggie M Fung; Pelin Aksit Ciris; Ting Song; Ajit Shankaranarayanan; Godtfred Holmvang; Sandeep N Gupta; Miguel Chaput; Robert A Levine; Jeremy Ruskin; Vivek Y Reddy; Andre D'avila; Anthony H Aletras; Stephan B Danik Journal: Europace Date: 2013-09-06 Impact factor: 5.214
Authors: Ehud J Schmidt; Zion T H Tse; Tobias R Reichlin; Gregory F Michaud; Ronald D Watkins; Kim Butts-Pauly; Raymond Y Kwong; William Stevenson; Jeffrey Schweitzer; Israel Byrd; Charles L Dumoulin Journal: Magn Reson Med Date: 2014-03 Impact factor: 4.668